. . . . . . . "[VIP (Vasoactive intestinal peptide) expression was decreased in Rhematoid Arthritis (RA) synovial fibroblasts (FLS) compared with Osteoarthritis (OA) FLS; in RA FLS, VPAC2 (VIP receptor type 2) mediates the antiinflammatory effects of VIP]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:16+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .